Mediators involved in the cancer anorexia-cachexia syndrome:: past, present, and future

被引:71
|
作者
Argilés, JM [1 ]
Busquets, S [1 ]
García-Martínez, C [1 ]
López-Soriano, FJ [1 ]
机构
[1] Univ Barcelona, Canc Res Grp, Dept Bioquim & Biol Mol, Fac Biol, Barcelona, Spain
关键词
cytokines; transcriptional factors; therapeutical strategies;
D O I
10.1016/j.nut.2005.02.003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The cachectic syndrome, characterized by a marked weight loss, anorexia, asthenia, and anemia is invariably associated with the presence and growth of the tumor and leads to a malnutrition status due to the induction of anorexia or decreased food-intake. In addition, the competition for nutrients between the tumor and the host leads to an accelerated starvation state, which promotes severe metabolic disturbances in the host, including hypermetabolism, which leads to an increased energetic inefficiency. Although the search for the cachectic factor(s) started a long time ago, and although many scientific and economic efforts have been devoted to its discovery, we are still a long way from knowing the whole truth. Present investigation is devoted to revealing the different signaling pathways, in particular transcriptional factors involved in muscle wasting. The main aim of the present review is to summarize and evaluate the different molecular mechanisms and catabolic mediators (both Immoral and tumoral) involved in cancer cachexia since they may represent targets for future promising clinical investigations. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:977 / 985
页数:9
相关论文
共 50 条
  • [41] Megestrol acetate in cancer patients with anorexia-cachexia syndrome: a meta-analysis
    Zhan, Ping
    Wang, Qin
    Qian, Qian
    Yu, Li-Ke
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (02) : 74 - 79
  • [42] Anorexia-cachexia syndrome in pancreatic cancer: Recent advances and new pharmacological approach
    Ronga, Ilaria
    Gallucci, Fernando
    Riccardi, Ferdinando
    Uomo, Generoso
    ADVANCES IN MEDICAL SCIENCES, 2014, 59 (01): : 1 - 6
  • [43] Leveraging a Team Mental Model to Develop a Cancer Anorexia-Cachexia Syndrome Team
    Portman, Diane G.
    Thirlwell, Sarah
    Donovan, Kristine A.
    Alvero, Christine
    Gray, Jhanelle E.
    Holloway, Rosa
    Ellington, Lee
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1046 - +
  • [44] Cancer anorexia-cachexia syndrome is characterized by more than one inflammatory pathway
    Gagnon, Bruno
    Murphy, Jessica
    Simonyan, David
    Penafuerte, Claudia A.
    Sirois, Jacinthe
    Chasen, Martin
    Tremblay, Michel L.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (03) : 1041 - 1053
  • [45] Corticotropin-Releasing Factor: A Key Element in Cancer Anorexia-Cachexia Syndrome
    Tsai, Minglun
    Fujitsuka, Naoki
    Amitani, Marie S.
    Amitani, Haruka
    Asakawa, Akihiro
    Hattori, Tomohisa
    Kase, Yoshio
    Inui, Akio
    GASTROENTEROLOGY, 2011, 140 (05) : S477 - S477
  • [46] Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis
    Bai, Yu
    Hu, Yunxia
    Zhao, Yanhua
    Yu, Xizhong
    Xu, Junwei
    Hua, Zhiyun
    Zhao, Zhiqiang
    SUPPORTIVE CARE IN CANCER, 2017, 25 (05) : 1651 - 1659
  • [47] Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin
    Anker, Stefan D.
    Coats, Andrew J. S.
    Morley, John E.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2015, 6 (04) : 275 - 277
  • [48] Family Members' Explanatory Models of Cancer Anorexia-Cachexia
    McClement, Susan
    HEALTHCARE, 2024, 12 (16)
  • [49] VALIDATION OF CANCER ANOREXIA-CACHEXIA SYNDROME IN GASTROINTESTINAL CANCER: MYTHS OR REALITY AT THAR DESERT OF INDIA
    Sanchetee, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 55 - 55
  • [50] Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat
    Borner, Tito
    Liberini, Claudia G.
    Lutz, Thomas A.
    Riediger, Thomas
    NEUROPHARMACOLOGY, 2018, 131 : 282 - 290